Annual Total Debt
$826.80 K
-$56.90 K-6.44%
December 31, 2023
Summary
- As of February 7, 2025, ENTO annual total debt is $826.80 thousand, with the most recent change of -$56.90 thousand (-6.44%) on December 31, 2023.
- During the last 3 years, ENTO annual total debt has risen by +$197.90 thousand (+31.47%).
- ENTO annual total debt is now -87.43% below its all-time high of $6.58 million, reached on December 1, 2015.
Performance
ENTO Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$159.70 K
-$196.30 K-55.14%
September 1, 2024
Summary
- As of February 7, 2025, ENTO quarterly total debt is $159.70 thousand, with the most recent change of -$196.30 thousand (-55.14%) on September 1, 2024.
- Over the past year, ENTO quarterly total debt has dropped by -$667.10 thousand (-80.68%).
- ENTO quarterly total debt is now -98.39% below its all-time high of $9.93 million, reached on September 1, 2016.
Performance
ENTO Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
ENTO Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.4% | -80.7% |
| 3 y3 years | +31.5% | -75.2% |
| 5 y5 years | +224.2% | -92.5% |
ENTO Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.8% | at low | -97.7% | at low |
| 5 y | 5-year | -48.5% | +31.5% | -97.7% | +51.1% |
| alltime | all time | -87.4% | +432.7% | -98.4% | -100.0% |
Entero Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $159.70 K(-55.1%) |
| Jun 2024 | - | $356.00 K(-94.9%) |
| Mar 2024 | - | $6.98 M(+744.6%) |
| Dec 2023 | $826.80 K(-6.4%) | $826.80 K(+257.5%) |
| Sep 2023 | - | $231.30 K(-42.4%) |
| Jun 2023 | - | $401.70 K(-37.7%) |
| Mar 2023 | - | $644.80 K(-27.0%) |
| Dec 2022 | $883.70 K(-14.2%) | - |
| Dec 2022 | - | $883.70 K(+198.9%) |
| Sep 2022 | - | $295.70 K(-37.5%) |
| Jun 2022 | - | $472.80 K(-35.9%) |
| Mar 2022 | - | $738.10 K(-28.4%) |
| Dec 2021 | $1.03 M(+63.8%) | $1.03 M(+163.8%) |
| Sep 2021 | - | $390.50 K(-28.2%) |
| Jun 2021 | - | $543.90 K(+32.5%) |
| Mar 2021 | - | $410.40 K(-34.7%) |
| Dec 2020 | $628.90 K(-60.8%) | $628.90 K(+495.0%) |
| Sep 2020 | - | $105.70 K(-98.1%) |
| Jun 2020 | - | $5.53 M(+66.5%) |
| Mar 2020 | - | $3.32 M(+106.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $1.60 M(+529.2%) | $1.60 M(-24.9%) |
| Sep 2019 | - | $2.14 M(-0.2%) |
| Jun 2019 | - | $2.14 M(+13.4%) |
| Mar 2019 | - | $1.89 M(+640.8%) |
| Dec 2018 | $255.00 K(-38.8%) | $255.00 K(>+9900.0%) |
| Sep 2018 | - | $0.00(-100.0%) |
| Jun 2018 | - | $307.90 K(-2.4%) |
| Mar 2018 | - | $315.60 K(-24.2%) |
| Dec 2017 | $416.50 K(+168.4%) | $416.50 K(+24.0%) |
| Sep 2017 | - | $336.00 K(-49.9%) |
| Jun 2017 | - | $671.10 K(+761.5%) |
| Mar 2017 | - | $77.90 K(-49.8%) |
| Dec 2016 | $155.20 K(-97.6%) | $155.20 K(-98.4%) |
| Sep 2016 | - | $9.93 M(+7.5%) |
| Jun 2016 | - | $9.24 M(+23.9%) |
| Mar 2016 | - | $7.46 M(+13.4%) |
| Dec 2015 | $6.58 M(+525.0%) | $6.58 M(>+9900.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00 |
| Dec 2014 | $1.05 M | - |
FAQ
- What is Entero Therapeutics annual total debt?
- What is the all time high annual total debt for Entero Therapeutics?
- What is Entero Therapeutics annual total debt year-on-year change?
- What is Entero Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Entero Therapeutics?
- What is Entero Therapeutics quarterly total debt year-on-year change?
What is Entero Therapeutics annual total debt?
The current annual total debt of ENTO is $826.80 K
What is the all time high annual total debt for Entero Therapeutics?
Entero Therapeutics all-time high annual total debt is $6.58 M
What is Entero Therapeutics annual total debt year-on-year change?
Over the past year, ENTO annual total debt has changed by -$56.90 K (-6.44%)
What is Entero Therapeutics quarterly total debt?
The current quarterly total debt of ENTO is $159.70 K
What is the all time high quarterly total debt for Entero Therapeutics?
Entero Therapeutics all-time high quarterly total debt is $9.93 M
What is Entero Therapeutics quarterly total debt year-on-year change?
Over the past year, ENTO quarterly total debt has changed by -$667.10 K (-80.68%)